Publications by authors named "David Lubaroff"

Claim this Profile
O
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.
Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson, William James Turbitt, Gal Wald, David M Lubaroff

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.
Lauren Z Davis, George M Slavich, Premal H Thaker, Michael J Goodheart, David P Bender, David M Lubaroff

Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal cortisol and survival in epithelial ovarian cancer.
Andrew Schrepf, Premal H Thaker, Michael J Goodheart, David Bender, George M Slavich, David M Lubaroff

Psychoneuroendocrinology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer vaccines in combination with additional treatment modalities.
Matthew A Uhlman, Megan T Bing, David M Lubaroff

Immunol Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine immunotherapy for prostate cancer: from mice to men.
David M Lubaroff, Daniel Vaena, James A Brown, Pamela Zehr, Karen C Griffith

Immunol Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.
Sean M Geary, Caitlin D Lemke, David M Lubaroff, Aliasger K Salem

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.
Andrew Schrepf, Lauren Clevenger, Desire Christensen, Koen DeGeest, David Bender, David M Lubaroff

Brain Behav Immun· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed mechanisms of action for prostate cancer vaccines.
Sean M Geary, Caitlin D Lemke, David M Lubaroff, Aliasger K Salem

Nat Rev Urol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
Lauren Clevenger, Andrew Schrepf, Desire Christensen, Koen DeGeest, David Bender, David M Lubaroff

Brain Behav Immun· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social influences on clinical outcomes of patients with ovarian cancer.
Susan K Lutgendorf, Koen De Geest, David Bender, Amina Ahmed, Michael J Goodheart, David M Lubaroff

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer vaccines in clinical trials.
David M Lubaroff

Expert Rev Vaccines· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.
Caitlin D Lemke, Jessica B Graham, Sean M Geary, Gideon Zamba, David M Lubaroff

Mol Pharm· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing.
Donald M Lamkin, Susan K Lutgendorf, David Lubaroff, Anil K Sood, Terry G Beltz

Brain Behav Immun· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.
Susan K Lutgendorf, Koen DeGeest, Laila Dahmoush, Donna Farley, Frank Penedo, David M Lubaroff

Brain Behav Immun· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.
Susan K Lutgendorf, Elizabeth Mullen-Houser, Daniel Russell, Koen Degeest, Geraldine Jacobson, David M Lubaroff

Brain Behav Immun· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.
Aliza Z Weinrib, Sandra E Sephton, Koen Degeest, Frank Penedo, David Bender, David M Lubaroff

Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results.
David M Lubaroff, Badrinath R Konety, Brian Link, Jack Gerstbrein, Tammy Madsen

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose as a prognostic factor in ovarian carcinoma.
Donald M Lamkin, Douglas R Spitz, Mian M K Shahzad, Bridget Zimmerman, Daniel J Lenihan, David M Lubaroff

Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
David M Lubaroff, Dev Karan

Adv Drug Deliv Rev· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.
Susan K Lutgendorf, Koen DeGeest, Caroline Y Sung, Jesusa M Arevalo, Frank Penedo, David Lubaroff

Brain Behav Immun· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Susan K Lutgendorf, Donald M Lamkin, Nicholas B Jennings, Jesusa M G Arevalo, Frank Penedo, David M Lubaroff

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.
Susan K Lutgendorf, Aliza Z Weinrib, Frank Penedo, Daniel Russell, Koen DeGeest, David M Lubaroff

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.
Susan K Lutgendorf, Donald M Lamkin, Koen DeGeest, Barrie Anderson, Minh Dao, David M Lubaroff

Brain Behav Immun· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive psychosocial factors and NKT cells in ovarian cancer patients.
Donald M Lamkin, Susan K Lutgendorf, Stephanie McGinn, Minh Dao, Heena Maiseri, David M Lubaroff

Brain Behav Immun· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
Dev Karan, Arthur M Krieg, David M Lubaroff

Int J Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis